Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,148,000 | 4,988,000 | 2,147,000 | 3,382,509 | 2,050,000 |
| Marketable Securities | 401,000 | 393,000 | 1,225,000 | 1,154,228 | 1,084,000 |
| Inventories | 3,515,000 | 3,525,000 | 3,314,000 | 3,064,832 | 2,965,000 |
| Other current assets | 5,890,000 | 5,773,000 | 5,847,000 | 6,037,890 | 5,282,000 |
| TOTAL | $14,954,000 | $14,679,000 | $12,533,000 | $13,639,458 | $11,381,000 |
| Non-Current Assets | |||||
| PPE Net | 8,395,000 | 8,092,000 | 8,026,000 | 7,828,481 | 7,464,000 |
| Intangibles | 6,691,000 | 6,276,000 | 5,864,000 | 5,832,156 | 4,706,000 |
| Other Non-Current Assets | 3,820,000 | 3,475,000 | 3,933,000 | 3,733,467 | 4,118,000 |
| TOTAL | $18,906,000 | $17,843,000 | $17,823,000 | $17,394,104 | $16,288,000 |
| Total Assets | $33,860,000 | $32,522,000 | $30,356,000 | $31,033,562 | $27,669,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,387,000 | 1,157,000 | 1,799,000 | 3,507,563 | 1,994,000 |
| Accounts payable and accrued liabilities | 5,143,000 | 5,312,000 | 5,329,000 | 4,866,013 | 5,142,000 |
| Other current liabilities | 195,000 | N/A | N/A | 1,719,493 | N/A |
| TOTAL | $8,798,000 | $8,266,000 | $9,279,000 | $10,355,278 | $9,029,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,801,000 | 12,566,000 | 8,114,000 | 6,990,922 | 4,885,000 |
| Other Non-Current Liabilities | 3,501,000 | 2,952,000 | 2,470,000 | 2,489,482 | 2,479,000 |
| TOTAL | $17,265,000 | $16,549,000 | $11,867,000 | $10,758,678 | $8,478,000 |
| Total Liabilities | $26,063,000 | $24,815,000 | $21,146,000 | $21,113,956 | $17,507,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,423,000 | 1,440,000 | 1,476,000 | 1,504,682 | 1,506,000 |
| Retained earnings | 4,099,000 | 4,255,000 | 5,717,000 | 6,481,630 | 6,818,000 |
| Other shareholders' equity | 642,000 | 441,000 | 428,000 | 359,026 | 337,000 |
| TOTAL | $7,486,000 | $7,438,000 | $8,916,000 | $9,612,518 | $9,879,000 |
| Total Liabilities And Equity | $33,549,000 | $32,253,000 | $30,062,000 | $30,726,474 | $27,386,000 |